MRVI is currently covered by 4 analysts with an average price target of $6.6. This is a potential downside of $0.78 (-10.57%) from yesterday's end of day stock price of $7.38.
Maravai Lifesciences Holdings's activity chart (see below) currently has 156 price targets and 111 ratings on display. The stock rating distribution of MRVI is 40% BUY and 60% HOLD.
Analysts' price targets on this stock were met 61.27% of the time, taking 122.24 days on average.
Highest price target for MRVI is $11, Lowest price target is $3, average price target is $6.6.
Most recent stock forecast was given by PAUL KNIGHT from KEYBANK on 12-Nov-2026. First documented stock forecast 14-Dec-2020.
Currently out of the existing stock ratings of MRVI, 2 are a BUY (40%), 3 are a HOLD (60%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 12-Nov-2026
$11
$3.46 (45.89%)
7 days ago
(12-Nov-2026)
4/8 (50%)
$3.3 (42.86%)
72
Hold Since 08-Aug-2024
$8
$0.46 (6.10%)
$11
2 months 10 days ago
(09-Sep-2026)
2/3 (66.67%)
$1.05 (15.11%)
36
Buy Since 15-Dec-2020
$5.5
$-2.04 (-27.06%)
$4.5
6 months 11 days ago
(08-May-2026)
5/6 (83.33%)
$0.65 (13.40%)
122
Hold Since 26-Feb-2026
$3
$-4.54 (-60.21%)
8 months 24 days ago
(26-Feb-2026)
6/11 (54.55%)
$-0.56 (-15.73%)
121
Buy Since 15-Dec-2020
$4
$5
1 years 12 days ago
(07-Nov-2025)
7/14 (50%)
$1.13 (39.37%)
181
What is MRVI (Maravai Lifesciences Holdings) average time for price targets to be met?
Which analyst most recently updated their price target on MRVI (Maravai Lifesciences Holdings)?
Which analyst has the most public recommendations on MRVI (Maravai Lifesciences Holdings)?
Which analyst is the currently most bullish on MRVI (Maravai Lifesciences Holdings)?
Which analyst is the currently most reserved on MRVI (Maravai Lifesciences Holdings)?